<DOC>
	<DOCNO>NCT01265446</DOCNO>
	<brief_summary>This study compare efficacy safety single dose lidocaine 8 mg + cetylpyridimium chloride ( CPC ) 2 mg lozenge single dose lidocaine 1 mg + CPC 2 mg lozenge treatment sore throat due common cold .</brief_summary>
	<brief_title>Efficacy Safety Sore Throat Lozenge Containing Lidocaine Cetylpyridinium Chloride Patients With Sore Throat Due Common Cold .</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Cetylpyridinium</mesh_term>
	<criteria>Patients sore throat due upper respiratory tract infection , recent onset ( within 48 hour ) Sore throat least moderate pain intensity History hypersensitivity study drug list excipients drug similar chemical class Evidence mouth breathe severe cough Evidence overt oropharyngeal bacterial fungal infection evidence lower respirator tract infection Severe renal , liver cardiac impairment Severe lung disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Sore throat , upper respiratory tract infection , lozenge lidocaine cetylpyridinium chloride .</keyword>
</DOC>